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Introduction
In mature B lymphocytes, binding of antigen or antireceptor anti-
body to the B cell receptor (BCR) complex causes a sustained 
rise in intracellular free Ca
2+, which, in turn, regulates prolifer-
ation and differentiation of the cells into either memory or 
 antibody-secreting ones (for review see Kurosaki, 2000). The 
increase in cytoplasmic Ca
2+ arises from two successive events: 
fi  rst, there occurs a transient Ca
2+ release from intracellular 
stores initiated by a rise in free inositol 1,4,5-trisphosphate (IP3; 
for review see Berridge et al., 2003). In turn, the emptying of 
Ca
2+ stores activates Icrac (Ca
2+ release activated) ion channels. 
The channels are Ca
2+ permeable, and Ca
2+ infl  ux via these 
channels results in a sustained elevation of cytoplasmic free 
Ca
2+ (Parekh and Penner, 1997; for review see Lewis, 1999). 
The molecular identity of the Icrac channels has yet to be fully 
determined, but recent studies demonstrate that the protein 
Orai1 (also called CRACM1) is an integral component of the 
channel and is associated with its Ca
2+ selectivity fi  lter (Vig 
et al., 2006a; Yeromin et al., 2006). Orai1, a gene product identifi  ed 
in severe combined immunodefi  ciency patients (Feske et al., 
2006), was discovered to be important in Icrac function 
through RNAi screens (Feske et al., 2006; Vig et al., 2006b; 
Zhang et al., 2005).
Tyrosine kinase activity is absolutely required for acti-
vation of the BCR–Ca
2+ signaling pathway (for review see 
Kurosaki, 2000). In the absence of kinase function, the sequence 
of molecular events linking BCR activation to IP3 production 
fails because the normal phosphorylation and activation of 
PLCγ, the enzyme that produces IP3, does not occur. The BCR 
complex is a multimer consisting of membrane Ig associated 
with Ig α/β heterodimers. The BCR complex interacts with and 
is phosphorylated by one or more of the following members of 
the Src kinase family: Lyn, Fyn, and/or Blk. In addition to the 
Src   kinase family, two other tyrosine kinases participate in the 
BCR–Ca
2+ signaling pathway: Syk (Syk family) and Btk (Tec 
family). All three tyrosine kinase families participate in PLCγ 
activation. Furthermore, tyrosine kinase–dependent activation 
of PLCγ is facilitated by adaptor or linker proteins such as Blnk 
(for review see Kurosaki, 2000). Whether these enzymes play 
a role in the events that link the emptying of Ca
2+ stores to Icrac 
activation has not been investigated directly. However, indirect 
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ctivation of the B cell receptor complex in B lym-
phocytes causes Ca
2+ release from intracellular 
stores, which, in turn, activates ion channels 
known as Icrac. We investigated the mechanisms that 
link Ca
2+ store release to channel gating in DT40 B 
lymphocyte cell lines genetically manipulated to suppress 
the expression of several tyrosine kinases: Btk, Lyn, Syk, 
and the Blnk adaptor molecule. The simultaneous but not 
the independent suppression of Lyn and Syk expression 
prevents the activation of Icrac without interfering with 
thapsigargin-sensitive Ca
2+ store release. Icrac activation 
by Ca
2+ is reversed in mutant cells by the homologous ex-
pression of the missing kinases. Pharmacological inhibi-
tion of kinase activity by LavendustinA and PP2 cause the 
same functional deﬁ  cit as the genetic suppression of en-
zyme expression. Biochemical assays demonstrate that 
  kinase activity is required as a tonic signal: targets must 
be phosphorylated to link Ca
2+ store release to Icrac 
  gating. The action of kinases on Icrac activation does not 
arise from control of the expression level of the stromal 
  interaction molecule 1 and Orai1 proteins.
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studies using pharmacological blockers of tyrosine kinase function 
have suggested that the enzymes may play a role in linking Ca
2+ 
store release and Ca
2+ infl  ux (Lee et al., 1993, Sargeant et al., 
1993a,b). In this study, we provide direct evidence of a role for   
kinases in the link between Ca
2+ store emptying and Icrac activa-
tion, and we identify some of the specifi  c enzymes involved.
 Two general classes of mechanisms have been proposed 
to link the store release of Ca
2+ to Icrac activation. The fi  rst 
class proposes that Icrac channels are structurally linked to the 
Ca
2+-containing stores and that their activation depends on a 
conformational coupling between the store and the plasma mem-
branes (Irvine, 1990; Petersen and Berridge, 1996; Kiselyov 
et al., 2001). The second class of mechanisms proposes that 
second messenger molecules accomplish this link through 
Ca
2+-dependent activation of target proteins. Over time, several 
plausible messenger proteins have been proposed: G proteins 
(Bird and Putney, 1993; Fasolato et al., 1993; Jaconi et al., 1993; 
Petersen and Berridge, 1995), PKC (Parekh and Penner, 1995), 
tyrosine kinases (Lee et al., 1993; Sargeant et al., 1993a,b; Rosado 
et al., 2000), Ca
2+ infl  ux factor (Randriamampita and Tsien, 
1993; Csutora et al., 1999), inositol 1,3,4,5-tetrakisphosphate 
(Luckhoff and Clapham, 1992), and cytochrome P-450 (Alvarez 
et al., 1992). Recently, however, a compelling case has been 
 developed that identifi  es stromal interaction molecule 1 (STIM1) 
as a messenger protein between Ca
2+ release and Icrac gating 
(Liou et al., 2005; Roos et al., 2005; Zhang et al., 2005). Simul-
taneous overexpression of STIM1 and Orai1 but not either 
alone facilitates the activation of Icrac (Peinelt et al., 2006). 
STIM1 is a membrane-bound Ca
2+-binding protein (its struc-
ture includes an EF hand) located in the ER. STIM1 acts as a 
Ca
2+ sensor: store Ca
2+ depletion causes STIM1 to cluster as 
discrete aggregates (puncta) that relocalize to ER membrane 
areas juxtaposed to the plasma membrane. STIM1 puncta co-
localize with Orai1, and Ca
2+ release–activated channels open 
at or near the sites where this protein nexus forms (Luik et al., 
2006; Wu et al., 2006).
To further our understanding of the mechanisms that couple 
Ca
2+ store release to Icrac gating, we investigated the features 
of Icrac and Ca
2+ store release in a chicken B lymphocytic 
cell line, DT40, in which the expression of specifi  c kinases 
can be genetically manipulated (Takata et al., 1994; Takata and 
Kurosaki, 1996; Ishiai et al., 1999). Our results indicate that 
Lyn or Syk tyrosine kinases are absolutely required to link 
the Ca
2+   released from intracellular stores to Icrac gating: when 
the simultaneous expression of the enzymes is genetically sup-
pressed, Icrac is not activated by the release of intracellular 
Ca
2+ stores. This effect is reversible and specifi  c and can be 
mimicked by the application of drugs that suppress kinase enzy-
matic activity in wild-type cells. The kinase effects do not arise 
from changes in the expression levels of either Orai1 or STIM1. 
Moreover, the release of Ca
2+ does not change the level of the 
phosphorylation of Syk, a measure of its enzymatic activity, and 
only small changes are detected in Lyn. Therefore, tonic signals 
that generate small pools of phospho-Lyn and -Syk appear to be 
required for Icrac activation.
Results
To investigate the role of tyrosine kinases in the molecular 
mechanisms underlying Icrac activation, we studied the electro-
physiological properties of wild-type and genetically modifi  ed 
DT40 cells engineered to suppress the expression of specifi  c 
proteins of interest.
Features of Icrac in wild-type DT40 cells
We measured voltage-clamped membrane currents at room 
temperature and tested the response to various agents that cause 
the release of Ca
2+ from intracellular stores: (1) thapsigargin 
(TG) blocks the constitutively active Ca
2+ transport into ER 
Figure 1.  Activation of Icrac in wild-type DT40 cells by different agents. 
Voltage-clamped membrane currents measured at room temperature in nor-
mal Ringer’s solution. Cells were held at 0 mV, and currents were activated 
by 160-ms duration voltage steps between –100 and 90 mV in 10-mV 
steps. I-V curves were measured in the steady state of activated Icrac cur-
rents between 2 and 10 min after cell stimulation. Currents activated at 
−100, −30, 0, 30, and 90 mV are shown. (A) Control cell treated with 
delivery vehicle alone (0.1% DMSO). (B) Treated with 1 μM extracellular 
TG. (C) Treated with 0.5 μM extracellular ionomycin. (D) Treated with 
60 μM IP3 delivered by diffusion from the lumen of the tight-seal electrode. 
(E) Treated with a 1:400 dilution of extracellular M4, a speciﬁ  c BCR antibody. 
To the right of each current set is that cell’s I-V curve measured after chemi-
cal activation. The current is the mean amplitude measured in the 60–160-ms 
interval after voltage step onset. To compare among cells of varying size, 
the current amplitude in each cell was normalized by the cell’s membrane 
surface, which was measured as membrane capacitance. Every one of the 
drugs tested activated the Icrac current, which is deﬁ  ned by its characteristic 
inward rectifying features.
Table I. Stationary current amplitude at –100 mV in wild-type DT40 
cells stimulated to cause Ca
2+ store release
Mode of stimulation Current amplitude n
DMSO carrier 0.13 ± 0.15 10
1 μM TG 1.25 ± 0.40 20
0.5 μM ionomycin 1.60 ± 0.35 10
60 μM IP3 1.29 ± 0.28 43
1:400 M4 antibody 1.09 ± 0.20 5
Current amplitude is given as pA/pF ± SEM.TYROSINE KINASES AND ICRAC GATING • CHUNG ET AL. 319
stores mediated by the ATP-dependent Ca
2+ pump (sarcoplasmic/
ER Ca
2+ ATPase); (2) M4, a mAb, specifi  cally activates the 
B cell antigen receptor (BCR), which, in turn, activates PLCγ 
and elevates cytoplasmic IP3; (3) IP3 delivered via the tight-seal 
electrode, which causes Ca
2+ release through  interaction with 
its specifi  c receptor on the ER membrane; and (4) ionomycin, an 
ionophore that renders membranes permeable to divalent cations. 
Each of the four reagents slowly activated a stationary inward 
membrane current at −90 mV (Fig. 1 and Table I). This current 
was unambiguously identifi  ed as Icrac because of its biophys-
ical features (Lewis and Cahalan, 1989; Hoth and Penner, 1992; 
McDonald et al., 1993; Zweifach and Lewis, 1993).
The characteristics of Icrac that we report were measured 
at various times, starting 120 s after fi  rst adding the stimulant 
and as long as 10 min thereafter. We did not observe remarkable 
differences throughout this time. We did not measure in detail 
the time course of Icrac development in our experiments, but a 
previous study indicates that IP3 fully activates the current 
within 150 s (Kiselyov et al., 2001), and TG activates the cur-
rent 60–120 s after adding the stimulant (see Fig. 6 and the sec-
tion Effect of TG on cytoplasmic Ca
2+…). We identifi  ed the 
current activated by the various stimulants as Icrac because 
(1) its I-V curve is inwardly rectifying and has a reversal potential 
between 40 and 50 mV; (2) it activates with a substantial delay 
relative to the moment of drug delivery; (3) it exhibits an anom-
alous mole fraction effect between Na
+ and Ca
2+ ions; (4) in the 
presence of divalent cations, it strongly selects divalent over 
monovalent cations but does not distinguish among some divalent 
cations (Ba
2+ is permeant, although somewhat less than Ca
2+); 
and (5) it is blocked by Cd
2+.
The ion selectivity features of Icrac activated by IP3 are 
  illustrated in Fig. 2. Current was activated by IP3 delivered by dif-
fusion from the lumen of the tight-seal electrode. In the same cell, 
we fi  rst measured the I-V characteristics of the IP3-dependent 
  currents in normal high Ca
2+ (10 mM) bathing solution and then 
in solutions free of divalent cations (with 2 mM EGTA), with Ca
2+ 
replaced by 10 mM Ba
2+. As expected for authentic Icrac, Ca
2+ is 
permeable, Ba
2+ is less permeable than Ca
2+, and the current is 
blocked by Cd
2+. Moreover, there is an anomalous mole fraction 
effect that explains the large current amplitude in the absence of 
external Ca
2+. We made the same observation in 10 other cells. 
Our results reproduce the features of Icrac in DT40 cells previ-
ously reported by others (Kiselyov et al., 2001; Mori et al., 2002).
Features of Icrac in tyrosine kinase–
deﬁ  cient DT40 cells
We examined membrane currents activated by intracellular 
Ca
2+ release in DT40 cell lines in which the expression of several 
tyrosine kinase enzymes was suppressed by homologous recom-
bination. We studied cells that failed to express Syk, Lyn, and Btk 
as well as cells lacking the adaptor molecule Blnk (B cell linker 
protein). Typical results in cells activated with IP3 loaded in the 
tight-seal electrode are illustrated in Fig. 3. Deletion of any one of 
the various tyrosine kinases alone did not eliminate the electrical 
response to IP3 or change the quantitative feature of Icrac (Table II). 
In contrast, when Lyn and Syk kinases were simultaneously 
 deleted,  IP3 stimulation entirely failed to elicit Icrac (Fig. 3 and 
Table II). That is, IP3-dependent Icrac activation appears to require 
the normal  function of either Lyn or Syk kinases.
The effect reported in Fig. 3 (and Table II) could simply 
be a consequence of a change in IP3 sensitivity. After all, the   
Figure 2.  Ion selectivity of Icrac in DT40 cells treated with 60 𝗍M intra-
cellular IP3. (A) Steady-state current amplitudes measured in the same cell 
between –100 and 90 mV in the sequential presence of extracellular Ringer’s 
solution containing 150 mM Na
+ and either free of divalent cations 
(squares; with 2 mM EGTA), with 10 mM Ca
2+ (triangles), or with 10 mM 
Ba
2+ (circles). (B) I-V curve of Icrac in different cells measured in the pres-
ence of 150 mM Na
+ and either 10 mM Ca
2+ (triangles) or 10 mM Ca
2+ 
with 2 mM of added Cd
2+ (diamonds).
Figure 3.  Activation of Icrac in DT40 cells by 60 𝗍M intracellular IP3. 
Voltage-clamped membrane currents measured at room temperature in cells 
bathed with normal Ringer’s solution. Cells were held at 0 mV. Currents ac-
tivated at −100, −30, and 0 mV are shown. To the right of each current 
set is that cell’s steady-state I-V curve after activation. (A–D) Blnk- (A), Lyn- (B), 
Btk- (C), and Syk-deﬁ  cient (D) cells. (E) Cell deﬁ  cient in both Lyn and Syk. 
The characteristic inwardly rectifying Icrac current is completely absent 
only in cells lacking both Lyn and Syk tyrosine kinases.JCB • VOLUME 177 • NUMBER 2 • 2007  320
concentration of IP3 required for the activation of Icrac is greater 
than that necessary to release Ca
2+ from intracellular stores 
(Parekh and Penner, 1997). Furthermore, the stores that release 
Icrac-activating Ca
2+ are but a specifi  c subset of all intracellular 
Ca
2+ stores in the cell (Hofer et al., 1998). We investigated the 
effectiveness of IP3 over a large concentration range (Fig. 4) and 
found that IP3 failed to activate Icrac even at the highest concen-
tration tested (360 μM). Thus, failure of Syk- and Lyn-defi  cient 
cells to respond to IP3 is not simply caused by a shift in the sen-
sitivity of Icrac to IP3.
Absence of Lyn and Syk speciﬁ  cally 
prevents Icrac channel gating
Failure of IP3-dependent Icrac activation could arise from one 
or all of the following mechanisms: failure of the IP3 receptor, 
failure of Ca
2+ release from intracellular stores, or failure of the 
link between Ca
2+ store release and Icrac activation. To distin-
guish among these possibilities, we investigated the effects of 
TG on the membrane current. TG inhibits the sarcoplasmic/ER 
Ca
2+ ATPase pump and, thus, causes the release of Ca
2+ from 
intracellular stores.
Fig. 5 illustrates voltage-clamped currents measured in the 
presence of TG in wild-type and Lyn- and Syk-defi  cient cells. TG 
activates Icrac in wild-type cells but failed to do so in the Lyn- 
and Syk-defi  cient ones (Fig. 5 and Table II). The concentration 
of TG we tested, 1 μM, is  10-fold higher than the concentra-
tion typically suffi  cient to saturate the effect (Premack et al., 
1994). The functional defect in Lyn- and Syk-defi  cient cells is 
not in the release of Ca
2+.
Effect of TG on cytoplasmic Ca
2+ 
in Lyn- and Syk-deﬁ  cient DT40 mutant cells
In wild-type DT40 cells bathed in normal Ringer’s solution, TG 
stimulation causes a sustained elevation of cytoplasmic free 
Ca
2+ that slowly reaches a peak in 100–150 s (Fig. 6 A; Broad 
et al., 2001; Ma et al., 2001; Mori et al., 2002). The sustained 
elevation arises from the sum of two sequential events: (1) the 
release of Ca
2+ from intracellular stores as a result of the TG 
  inhibition of Ca
2+ pumps and (2) the infl  ux of Ca
2+ from the 
extracellular space through Icrac channels activated by the initial 
rise in free Ca
2+. To resolve Ca
2+ store release from membrane 
Ca
2+ infl  ux, it is common to measure the TG-dependent Ca
2+ 
response in the absence of extracellular Ca
2+ (4 mM EGTA 
added to the DT40 Ringer’s solution;  100 nM of free Ca
2+). 
Under this condition, TG causes an increase in cytoplasmic 
Ca
2+ (released from ER) that is smaller in amplitude and much 
shorter in duration than the changes observed while in the con-
tinuous presence of extracellular Ca
2+ (Fig. 6 B).
 We explored the functional role of Lyn and Syk on 
TG-dependent changes in cytoplasmic free Ca
2+. In Lyn- and 
Figure 4.  Dependence of Icrac amplitude on intracellular IP3 concentra-
tion in wild-type and mutant cells. Current amplitude measured at −100 mV 
after cell activation. Closed circles are the mean (±SEM [error bars]) amp-
litude measured in wild-type (wt) cells, and open circles are data measured 
in Lyn- and Syk-deﬁ  cient cells. Lyn- and Syk-deﬁ  cient cells were not acti-
vated even at the highest IP3 concentration tested.
Figure 5.  Activation of Icrac in DT40 cells with 1 𝗍M extracellular TG. 
Voltage-clamped membrane currents measured in cells bathed in normal 
Ringer’s solution. Currents activated at −100, −30, 0, 30, and 90 mV are 
shown. To the right of each current set is the steady-state I-V curve for that 
cell. (A) Wild-type (wt) cell. (B) Lyn- and Syk-deﬁ  cient cell. In the absence of 
tyrosine kinases, Icrac current is not activated by TG.
Table II. Stationary current amplitude at –100 mV in wild-type and mutant DT40 cells stimulated to cause Ca
2+ store release
Cell type Current amplitude
60 𝗍M IP3 n 1 𝗍M TG n
Wild type 1.29 ± 0.28 48 1.25 ± 0.40 20
blnk
−/− 0.26 ± 0.21 12 0.49 ± 0.12 6
btk
−/− 1.24 ± 0.27 11 ND ND
lyn
−/− 1.50 ± 0.44 12 ND ND
syk
−/− 1.63 ± 0.50 7 ND ND
lyn/syk
−/− 0.18 ± 0.20 28 0.30 ± 0.15 9
Current amplitude is given as pA/pF ± SEM.TYROSINE KINASES AND ICRAC GATING • CHUNG ET AL. 321
Syk- defi  cient cells maintained in normal Ringer’s solution, TG   
stimulation caused a small and transient increase in cytoplasmic 
free Ca
2+ (Fig. 6 C) rather than the large and sustained change 
observed in normal cells (Fig. 6 A). On the other hand, the re-
sponse to TG in mutant cells suspended in a Ca
2+-free medium 
(Fig. 6 D) was not different from that of normal cells (Fig. 6 B): 
TG caused the expected small and transient increase in free Ca
2+. 
We made similar observations in six additional experiments. 
That is, in Lyn- and Syk-defi  cient cells, the TG-dependent re-
lease of Ca
2+ from intracellular stores is not different from that 
in normal cells, but the absence of tyrosine kinases causes a 
failure of Icrac channel activation.
The functional defect in Lyn- and Syk-
deﬁ  cient cells is rescued by heterologous 
expression of the enzymes
The failure of Icrac activation in Lyn- and Syk-defi  cient cells 
could arise specifi  cally from the absence of tyrosine kinase activity 
but also from an unintended consequence of the genetic mani-
pulation. If the failure of Icrac gating depends specifi  cally on the 
expression of active kinases, restoring enzyme expression in the 
mutant cells should restore the wild-type–like Ca
2+ response.
We tested this thesis by transfecting lyn/syk
−/− cells with 
DNA constructs that command the homologous expression of 
the Lyn and Syk proteins alone or in combination. Furthermore, 
the DNA constructs commanded the expression of a reporter 
GFP in tandem with the kinase. This tandem expression allowed 
us to identify successfully transfected cells, which are expected 
to express the kinases, because they also fl  uoresced under chro-
matically appropriate illumination. We used an imaging instru-
ment to measure cytoplasmic Ca
2+, an alternative to the mass 
measurement reported in the previous section and in Fig. 6, to 
permit us to analyze the cytoplasmic Ca
2+ in a population con-
sisting of more than a single cell type. We could distinguish the 
response of reconstituted cells (fl   uorescent cells expressing 
GFP) from that of Lyn- and Syk-defi  cient ones that had been 
identically treated but did not express the kinases.
Cells were loaded with Fura2, and the emission intensity 
of individual images, which were excited at 340 and 380 nm, 
was measured. The ratio of these intensities reports free Ca
2+ 
concentration. The ratio in individual cells was averaged. The 
time course of the mean change in free cytoplasmic Ca
2+ in a 
cell batch is illustrated in Fig. 7 (each cell averaged). Wild-type 
cells were initially bathed in normal Ringer’s solution. They 
were then locally superfused with a Ca
2+-free Ringer’s solution 
(4 mM EGTA) also containing 1 μM TG. A rise in the emission 
intensity ratio (F340/F380) revealed the expected rise in free 
Ca
2+ as a result of release from intracellular stores (Fig. 7 A). 
The superfusing solution was then switched to one containing 
the same 1 μM TG but with added Ba
2+ (10 mM total and 8 mM 
of free Ca
2+). The addition of Ba
2+ caused a second transient in 
the F340/F380 emission ratio (Fig. 7 A). The second transient 
arises from binding to Fura2 of Ba
2+ that fl  ows into the cells 
through the Icrac channels activated by the TG-dependent Ca
2+ 
transient (Vazquez et al., 2002). Ba
2+ was used to ensure that 
changes in Fura2 fl  uorescence arose specifi  cally from the acti-
vation of Icrac (and associated Ba
2+ infl  ux), not from Ca
2+ fl  ux 
originating in unrecognized cellular sources or infl  ux through 
other Ca
2+-permeable ion channels (see Fig. 9; compare this 
data with Vazquez et al., 2002).
In contrast, in Lyn- and Syk-defi  cient cells tested with the 
same protocol, TG/EGTA Ringer’s solution caused the same 
initial transient release of Ca
2+ from the ER observed in wild-
type cells, but adding Ba
2+ to the extracellular medium did not 
change Fura2 cytoplasmic fl  uorescence (Fig. 7 B). That is, in 
Lyn- and Syk-defi  cient cells, Icrac channels are not active and, 
thus, extracellular Ba
2+ cannot fl  ow into the cell to interact 
with Fura2. The same observation was made in 10 repeat 
experiments. Just like the fi  ndings in the measurements of cell 
suspensions, these results verify that lack of tyrosine kinase 
activity causes a loss of the linkage between Ca
2+ store release 
and Icrac activation.
We measured TG-dependent Ca
2+ changes in transiently 
reconstituted mutant cells that expressed tyrosine kinases 24 h 
after DNA transfection. In image analysis, we distinguished 
cells by their GFP fl  uorescence: GFP-negative cells were 
mutant lyn/syk
−/− cells, whereas GFP-positive ones expressed 
the specifi  c kinase of interest. In general,  20% of the cells 
expressed GFP under our experimental protocol, but the level 
of expression varied among cells. We measured Ca
2+ only in   
the cells expressing the highest level of GFP,  5–10% of the 
cells. Typical results are illustrated in Fig. 7. The same obser-
vations were made in three different experiments for each   
transfection condition.
Figure 6.  Effects of 1 𝗍M TG on cytoplasmic free Ca
2+ in 
populations of normal and mutant DT40 cells. Cytoplasmic 
Ca
2+ was measured with the ﬂ  uorescent  Ca
2+ indicator 
Indo1. An increase in the 400:500-nm emission intensity ratio 
reﬂ  ects a rise in cytoplasmic Ca
2+. Cells were suspended ei-
ther in normal Ringer’s solution (with 1 mM Ca
2+) or in Ca
2+-
free Ringer’s solution (with 4 mM EGTA). (A) In wild-type (wt) 
cells, TG application in normal Ringer’s solution caused a sus-
tained elevation of cytoplasmic Ca
2+. (B) In the presence of 
EGTA, the TG-dependent Ca
2+ rise was transient, and, after 
reaching a peak, it returned to nearly the starting value de-
spite the continuous presence of TG. (C and D) In Lyn- and 
Syk-deﬁ  cient cells, TG caused a nearly identical response in 
the presence of Ca
2+ (C) or in its absence (D). The response 
was a small, transient rise in free Ca
2+ that arises from the 
TG-dependent release of Ca
2+ from intracellular stores.JCB • VOLUME 177 • NUMBER 2 • 2007  322
Kinase-defi  cient cells that did not reconstitute the expression 
of tyrosine kinases but were nonetheless subjected to the electro-
poration protocol of transfection behaved indistinguishably 
from untreated Lyn- and Syk-defi  cient cells. Stimulation with 
TG/EGTA Ringer’s solution caused a release of Ca
2+ from intra-
cellular stores, but Icrac was not activated, and extracellular 
Ba
2+ failed to fl  ow into the cells (Fig. 7, C–E). In contrast, the 
expression of kinases Lyn (Fig. 7 C) or Syk (Fig. 7 D) alone or 
together (Fig. 7 E) restored wild-type–like behavior in these 
cells. TG caused intracellular Ca
2+ release, which activated 
  Icrac channels that, in turn, sustained Ba
2+ infl  ux.
Examination of data in Fig. 7 reveals that the expression 
of tyrosine kinases restored Icrac gating, but it should be noted 
that the Ba
2+-dependent fl  uorescence changes are not quantita-
tively similar to the response in wild-type cells and, in fact, differed 
among the various transfected cell batches tested. This is not 
surprising because we could not control the level of expression 
of the kinases in the transfected cells, and, moreover, there is 
no reason to expect that these levels would be identical to those 
in wild-type cells or amid different cell batches. Nonetheless, 
restoring kinases in Lyn- and Syk-defi  cient cells always rescued 
the cell phenotype, indicating that functional defects in the defi  -
cient cells arise specifi  cally from the lack of these kinases. As 
we observed in electrical studies of mutant cell lines (Fig. 3), 
the presence of either Lyn or Syk alone is suffi  cient to obtain 
normal function.
Mechanisms of Lyn and Syk action
Although the detailed molecular mechanisms whereby Lyn and 
Syk function to link Ca
2+ release to Icrac gating remain to be 
determined, we tested two possibilities: (1) that these mecha-
nisms act on the events linking Ca
2+ release and channel gating 
and (2) that the enzymatic activity of the kinases change in the 
course of Ca
2+ store release and/or channel gating.
A parsimonious thesis suggests that kinases act on the 
molecular events that link Ca
2+ release and channel gating. 
However, it can be argued that the action of kinases is not 
  direct but arises from long-term effects of enzyme activity on 
events such as gene expression or cellular protein traffi  cking. 
To assess whether the kinase action is immediate and direct or 
not, we tested the effectiveness of drugs known to act as spe-
cifi  c tyrosine kinase inhibitors. If the role of kinase activity is 
direct, drug treatment should have the same effect on TG-
  dependent Icrac activation as on the genetic suppression of 
enzyme expression.
We tested the effectiveness of two well-established kinase 
inhibitors: LavendustinA, a specifi  c tyrosine kinase inhibitor that 
does not distinguish among enzyme types (Onoda et al., 1989; 
Ping et al., 1999), and PP2, a selective inhibitor of the Src family 
tyrosine kinase. We fi  rst used an electrophysiological assay to test 
the effect of LavendustinA on TG-dependent Icrac activation. 
Cells were treated with 10 μM LavendustinA starting 10 min 
  before the functional assay and throughout the assay. Electro-
physiological data in Fig. 8 are typical of experiments that were 
repeated fi  ve times. In normal cells, TG caused activation of an 
inward current at −90 mV that developed slowly and reached its 
maximum steady amplitude  60–100 s after initiating TG stimu-
lation (Fig. 8 A, inset). The I-V curve of this TG-dependent 
  current was measured by taking the difference in I-V curves 
  before TG stimulation (time 0 data point) and 85 s after initiating 
Figure 7.  Restoration of TG-dependent Icrac 
activation by Lyn and/or Syk homologous 
expression in lyn/syk
−/− cells. Cytoplasmic 
Fura2 emission ﬂ  uorescence intensity ratio at 
340 and 380 nm was measured in individual 
cells and averaged. (A) Wild-type cells stimu-
lated by 1 μM TG in a Ca
2+-free Ringer’s solu-
tion (with 4 mM of added EGTA) demonstrated 
a transient release of Ca
2+ from the ER stores. 
Switching to an extracellular solution con-
taining Ba
2+ added to the EGTA-containing 
Ringer’s solution (10 mM Ba
2+ added, yielding 
8 mM of free Ca
2+) caused a change in Fura2 
ﬂ  uorescence as a result of Ba
2+ inﬂ  ux through 
activated Icrac channels (mean of 42 cells). 
(B) Lyn- and Syk-deﬁ  cient cells. TG caused the re-
lease of intracellular Ca
2+ stores, but the addi-
tion of extracellular Ba
2+ did not cause changes 
in intracellular Fura2 ﬂ  uorescence  because 
Ba
2+ inﬂ  ux does not occur in the absence of 
active Icrac channels (mean of 19 cells). Pan-
els on the right illustrate results from measure-
ments in Lyn- and Syk-deﬁ  cient cells reconstituted 
to express Lyn or Syk alone or together. Be-
cause the heterologous protein was in fusion 
with GFP, cells in a ﬁ  eld of view were identi-
ﬁ   ed as kinase expressing and GFP positive 
(closed circles) or as lyn/syk
−/− and GFP neg-
ative (open circles). The response of Lyn- and Syk-deﬁ  cient cells is the same in all panels (C, mean of 35 cells; D, 20 cells; E, 25 cells). TG causes intracellular 
Ca
2+ release, but Ba
2+ cannot enter through closed Icrac channels. On the other hand, the successful expression of tyrosine kinases (C, Lyn alone, mean 
of nine cells; D, Syk alone, three cells; E, both, three cells) allows Icrac activation by released Ca
2+, and, thus, changes in Fura2 ﬂ  uorescence are observed 
in these cells when the bathing solution is switched to one containing Ba
2+. In E, the dotted line identiﬁ  es the moment Ba
2+ was ﬁ  rst added to the bathing 
solution. It corresponds to the transition from gray to black in the horizontal bar.TYROSINE KINASES AND ICRAC GATING • CHUNG ET AL. 323
TG stimulation (time 165 s data point). The difference in the I-V 
curve thus computed is typical of Icrac (Fig. 8 A). In contrast, in 
LavendustinA-treated cells, TG failed to activate an inward current 
at −90 mV (Fig. 8 B, inset). In three different LavendustinA-
treated cells, we followed the current for up to 20 min after initiat-
ing TG stimulation and did not observe any substantial activation. 
Also, in the presence of LavendustinA, there was no difference in 
the I-V curves measured at time 0 and at 165 s (Fig. 8 B).
Having demonstrated that LavendustinA specifi  cally pre-
vents TG-dependent Icrac activation, we also tested the drug 
  effect in a single-cell Ca
2+ imaging assay of Fura2-loaded cells. 
As illustrated in Fig. 7 A, in wild-type cells and in the absence 
of extracellular Ca
2+, TG causes a transient increase in cyto-
plasmic Ca
2+ because of the cation release from intracellular 
stores. If Ba
2+ is then added to the extracellular medium, the 
cation fl  ows into the cell only if Icrac channels have been acti-
vated and causes a second, prominent increase in the Fura2 
emission intensity ratio. In contrast, in Lyn- and Syk-defi  cient 
cells, Icrac is not activated, and, therefore, extracellularly added 
Ba
2+ does cause any changes in Fura2 fl  uorescence (Fig. 8 C). 
The same phenotype is observed in LavendutinA-treated cells: 
TG causes an initial rise in cytoplasmic Ca
2+, but the addition of 
extracellular Ba
2+ does not cause any change in the Fura2 emis-
sion intensity (Fig. 8 D).
We tested the effect of PP2, a potent and specifi  c inhibitor 
of the Src kinase family (that is, a specifi  c inhibitor of Lyn), on 
TG-dependent Ca
2+ fl  uxes in suspensions of cells loaded with 
the Ca
2+ indicator Indo1 (Fig. 9). Again, in wild-type cells, 1 μM 
TG delivered in the presence of EGTA caused a transient 
  increase in cytoplasmic free Ca
2+, which was followed by a 
much larger and sustained change in concentration when Ca
2+ 
was added to the extracellular medium (Fig. 9 A). In Lyn- and 
Syk-defi  cient cells, TG caused the initial rise in cytoplasmic 
Ca
2+, but, because Icrac channels are not activated, the added 
external Ca
2+ caused only a modest change in cytoplasmic free 
Ca
2+ when compared with the normal cells (Fig. 9 B). Treat-
ment of wild-type cells with 20 μM PP2 caused a functional 
phenotype that was indistinguishable from that of the Lyn- and 
Syk-defi  cient cells. In PP2-treated cells, TG added in a medium 
free of divalent cations caused a transient increase in cytoplasmic 
Ca
2+, but the addition of Ca
2+ to the extracellular medium did 
not cause any further changes in cytoplasmic free Ca
2+ (Fig. 9 C). 
These pharmacological fi  ndings together with the results of 
genetic manipulations demonstrate that Lyn activity is required 
for Icrac gating even if Syk activity is unchanged. That is, the 
tyrosine kinases are required, and Lyn (and other Src   kinases) is 
likely upstream of Syk in this pathway.
Biochemical assay of Lyn and 
Syk phosphorylation activity
We measured the level of phosphorylation of Lyn and Syk 
  kinase proteins. This autophosphorylation is a parameter that 
can refl  ect kinase activity. To increase sensitivity, all tyrosine-
phosphorylated proteins in cell lysates were fi  rst  immuno-
precipitated with panspecifi  c phosphotyrosine mAbs. These 
immunoprecipitates were then probed in a Western blot using 
antibodies that bound to specifi  c phosphotyrosine residues in 
Lyn and Syk (Fig. 10 A).
Figure 8.  The speciﬁ  c tyrosine kinase inhibi-
tor LavendustinA blocks the activation of Icrac 
in wild-type DT40 cells. (A and B) Electrophysi-
ological assay. Membrane voltage was held at 
0 mV, and the difference in current amplitude 
in response to −90-mV steps was measured 
repeatedly every 3 s and box car averaged 
over three adjacent data points. In the graph, 
time 0 is the moment whole cell mode was ﬁ  rst 
achieved. 90 s thereafter, the cell bathing solu-
tion was switched to one containing 1 μM TG. 
(A) In a normal cell, TG slowly activated an in-
ward current that reached a ﬁ  nal, stationary 
value  60 s after TG superfusion began (in-
set). The I-V curve of the TG-dependent current 
was measured as the difference in I-V curves 
acquired at time 0 s and at 85 s after initiating 
TG superfusion. This I-V curve is typical of Icrac. 
(B) TG, in contrast, did not cause any cur-
rent change in cells treated with LavendustinA 
(inset). Because there are no TG-dependent 
currents in LavendustinA-treated cells, the dif-
ference in I-V curves acquired at time 0 and at 
85 s after initiating TG superfusion is essen-
tially ﬂ  at. (C and D) Ca
2+ imaging assay. (C) In 
Lyn- and Syk-deﬁ   cient cells, stimulation with 
1 μM TG in a Ca
2+-free Ringer’s solution (with 
4 mM EGTA) caused a rise in intracellular 
Ca
2+ (increase in Fura2 ﬂ  uorescence  F340/
F380 emission intensity), but adding Ba
2+ 
tothe EGTA-containing Ringer’s solution (10 mM 
Ba
2+ added, yielding 8 mM of free Ca
2+) to the extracellular medium did not cause further changes in Fura2 ﬂ  uorescence (mean of 45 individual cells). 
(D) Wild-type cells were incubated for 10 min with 10 μM LavendustinA and assayed in the continuing presence of the drug. These drug-treated cells exhibit 
the same functional behavior as Lyn- and Syk-deﬁ  cient ones: Icrac is not activated, and Ba
2+ added after TG stimulation does not cause the enhancement 
in Fura2 emission intensity observed in wild-type cells. Error bars represent SEM.JCB • VOLUME 177 • NUMBER 2 • 2007  324
TG stimulation had different effects on the two enzymes. 
Syk exhibited a low level of phosphorylation before stimula-
tion, which was not detectably changed by TG. In contrast, Lyn 
had a low level of phosphorylation before stimulation, and TG 
increased this level  2.5-fold. As a control, we used immuno-
precipitates isolated from Lyn- and Syk-defi  cient cells, and, as 
expected, there was no detectable signal for either of these 
  kinases (Fig. 10 A). Also, we measured the phosphorylation of 
these kinases in BCR-stimulated cells, and, consistent with pre-
vious observations (Mizuguchi et al., 1992; Ma et al., 2001), we 
observed a stimulated phosphorylation of approximately seven-
fold for each kinase.
Expression levels of STIM1 protein 
and of STIM1 and Orai1 mRNA 
in Lyn- and Syk-deﬁ  cient cells
Recent experiments have demonstrated that two membrane-
  associated proteins, STIM1 (Liou et al., 2005; Roos et al., 2005; 
Zhang et al., 2005) and Orai1 (Feske et al., 2006, Vig et al., 
2006b), participate in the events linking Ca
2+ store release to 
Icrac channel activation in lymphocytes. It is possible, then, 
that the effects of Lyn and Syk arise from their action on these 
proteins. Future work must explore whether these proteins are 
phosphorylated and what role tyrosine kinases might play. In 
this study, we tested the possibility that Syk and Lyn act as regu-
lators of the expression of either or both of these proteins. We 
tested this thesis by assaying the protein expression level of 
STIM1 and the mRNA expression level of both STIM1 and 
Orai1. We fi  nd that none of these is detectably different in wild-
type and mutant cells.
STIM1 protein levels were measured in Western blots. 
Individual lanes in SDS-PAGE were loaded with the same total 
protein amount. The relative amount of protein identifi  ed with 
an STIM1 antibody was assessed by chemiluminescence. Sam-
ples from wild type and the following mutants were run along-
side each other in the same gel: lyn
−/−,  syk
−/−,  lyn/syk
−/−, 
blnk
−/−, and IP3
−/− receptor (Fig. 10 B). The expression levels 
of tubulin in each sampled lane were also measured to confi  rm 
that the amount of protein loaded in each lane was essentially 
the same (Fig. 10 B). There was no detectable difference in the 
level of STIM1 protein between wild type and the various mu-
tant cells tested.
mRNA levels of STIM1 and Orai1 were assayed with 
semiquantitative RT-PCR. Total cell RNA was used to synthe-
size cDNA, which, in turn, was amplifi   ed using PCR. The 
amount of gene-specifi  c DNA produced under identical reac-
tion conditions was compared for STIM1 and Orai1-specifi  c 
primers in wild type and in the following mutants: lyn
−/−, 
syk
−/−, lyn/syk
−/−, blnk
−/−, and IP3
−/− receptor. PCR products 
were loaded at various dilutions into the lanes of an agarose gel 
and separated by size. The level of β-actin mRNA was also 
  assessed in each of the cell samples. The amount of DNA in 
each well was quantifi  ed by the intensity of fl  uorescence in images 
of ethidium bromide–stained gels (Fig. 10 C). There was no 
  detectable difference in the STIM1 and Orai1 mRNA levels 
  between wild type and the various mutant cells tested.
Discussion
In B lymphocytes, binding of antigen or antireceptor antibody to 
the BCR complex recruits and activates tyrosine kinases as part 
of the events that lead to the production of IP3 (Rawlings, 1999; 
Wollscheid et al., 1999; for reviews see Kurosaki, 2000; Wienands, 
2000). Results presented in the current study  indicate that these 
kinases also play a role in the link between the IP3-dependent 
release of Ca
2+ from ER intracellular stores and activation of the 
Icrac ion channels in the plasma membrane. We compared the 
electrophysiological features of Icrac and changes in free cyto-
plasmic Ca
2+ between wild-type and Lyn- and Syk-defi  cient 
DT40 cells and found that cells simultaneously lacking Lyn and 
Syk tyrosine kinases fail to activate Icrac after the release of 
Ca
2+ stores. Interestingly, the genetic deletion of either enzyme 
alone did not prevent Icrac activation, revealing redundancy in 
the biological function of these kinases in this response. The 
physiological effects on Icrac and cytoplasmic Ca
2+ fl  ux of 
pharmacological blockers of these enzymes leads us to suggest 
that the enzymes may operate in a sequential cascade with the 
Figure 9.  The speciﬁ  c Src tyrosine kinase inhibitor PP2 blocks the activa-
tion of Icrac in wild-type DT40 cells. Cytoplasmic free Ca
2+ measured in a 
suspension of cells loaded with Indo1. (A) Normal cells suspended in Ca
2+-
free Ringer’s solution (4 mM EGTA) respond to stimulation by 1 μM TG 
with a small, transient increase in free Ca
2+. Addition of external Ca
2+ to 
the EGTA-containing Ringer’s solution (5 mM Ca
2+ added, yielding 1 mM 
of free Ca
2+) causes a large increase in cytoplasmic Ca
2+ as a result of 
cation inﬂ  ux through activated Icrac channels. (B) Lyn- and Syk-deﬁ  cient 
cells. In response to 1 μM TG in a Ca
2+-free Ringer’s solution, there is a 
small, transient increase in Ca
2+ similar to that in wild-type (wt) cells. The 
addition of extracellular Ca
2+ causes a small additional increase in free 
Ca
2+ that is smaller in extent than that observed in wild-type cells. (C) Wild-
type cells treated with 20 μM PP2. The functional behavior of these cells is 
indistinguishable from the Lyn- and Syk-deﬁ  cient ones. In the absence of 
extracellular Ca
2+, TG causes a small and transient Ca
2+ release from 
intracellular stores. Icrac is not activated, and, therefore, the addition of 
extracellular Ca
2+ does not cause the large and sustained increase in free 
Ca
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Src family enzyme (Lyn) upstream from Syk. The failure to 
activate Icrac in the Lyn- and Syk-defi  cient cells refl  ects that 
protein phosphorylation is a required event in the mechanism 
that couples the emptying of Ca
2+ stores to channel activation or 
in the function of the channels themselves. These alternatives 
cannot now be unequivocally discerned.
There are no previous studies on the electrical properties 
of lymphocytes with the genetically suppressed expression of 
tyrosine kinases. However, the hypothesis that tyrosine kinases 
may play a role in the link between Ca
2+ store release and Icrac 
activation has been proposed previously (Lee et al., 1993; 
Sargeant et al., 1993a,b; Rosado et al., 2000). Lymphocytes of 
mice in which the Btk-related Itk tyrosine kinase is knocked out 
respond to T cell receptor activation with a normal release of 
intracellular Ca
2+ stores, but Icrac activation by TG is less than 
in wild-type animals (Liu et al., 1998). In addition to observations 
in animals subjected to genetic manipulation, a possible role for 
tyrosine kinases in lymphocyte Ca
2+ transduction paths has 
been suggested by experimental observations of some effects of 
the pharmacological inhibition of tyrosine kinase activity 
(Whisler et al., 1991; Mizuguchi et al., 1992; Schieven et al., 
1993; Nagao et al., 1996).
Currently, the mechanisms that couple Ca
2+ store release 
to Icrac gating fall into two main categories: (1) physical coupling 
mechanisms propose that activation of the IP3 receptors are di-
rectly linked through conformational changes to the opening of 
Icrac channels. An alternative form of physical coupling, the 
vesicle fusion hypothesis proposes a fusionlike event between 
intracellular vesicles and the plasma membranes that delivers 
Icrac channels or their activators to the plasma membrane. 
Vesicle fusion is mediated by SNARE proteins. (2) Messenger 
mechanisms propose that the released Ca
2+ is detected by 
particular cytoplasmic Ca
2+ sensor molecules that, in turn, gate 
channel activity.
The direct coupling hypothesis was developed to explain 
fi  ndings that Icrac fails to occur after pharmacological treat-
ments expected to disrupt cytoskeletal elements (for example, 
cytochalasin D [Patterson et al., 1999], calyculin A [Patterson 
et al., 1999], 2APB [Patterson et al., 1999], or clostridium C3 
transferase injection [Yao et al., 1999]). Direct coupling sup-
poses that molecular receptors in the ER membranes, IP3 recep-
tors, or ryanodine receptors are linked to Icrac activation through 
conformational changes. In lymphocytes in particular, this hypo-
thesis is unlikely because mutant DT40 cells lacking all IP3 
  receptor isoforms exhibit normal TG-activated Icrac (Prakriya 
and Lewis, 2001) and ryanodine receptor knockout animals 
have normal T cell activation (Takeshima et al., 1996).
The vesicle fusion hypothesis (for review see Rosado 
et al., 2005) was developed to explain the fact that interference 
with the function of all or even some of the various proteins that 
constitute the SNARE complex can block TG-dependent Ca
2+ 
elevation. Although it is evident that SNARE protein can alter 
the cell’s Ca
2+ response, it remains questionable whether their 
specifi  c activation by IP3-linked events is required in the course 
of normal events linking Ca
2+ store release and Icrac gating 
(Scott et al., 2003).
Recent studies have identifi  ed two novel proteins, STIM1 
and Orai1, that participate in the signaling between store Ca
2+ 
Figure 10.  Biochemical analysis of Lyn and 
Syk autophosphorylation activity in wild-type 
and mutant cells. Analysis of the expression of 
STIM1 and Orai1 in wild-type and mutant 
cells. (A) BCR- and TG-stimulated Lyn/Syk ac-
tivity in DT40 cells. Wild-type (wt) or Lyn- and 
Syk-deﬁ   cient cells were stimulated with anti-
BCR antibody (M4) or with TG. Western blots 
of immunoprecipitates of tyrosine phospho-
proteins isolated from the cells before and 60 
or 300 s after TG or the M4 stimulation (as 
labeled). The same blot was successively probed 
with antibodies speciﬁ  c for the activation loop 
in Syk (P-Y352) or Src (P-Y416) kinases. The 
extent of antibody binding was quantiﬁ   ed 
in relative units of activity (phosphorylation 
index). The levels of IgG are also shown to 
demonstrate that the total amount of tyrosine-
phosphorylated protein in each lane is similar. 
The bar graphs are means ± SEM (error bars) 
of the phosphorylation index in ﬁ  ve different 
experiments measured from the absolute val-
ues of gray level (at 10-bit resolution) in the 
original blots. The images displayed for each 
ofthe various antibodies tested were indepen-
dently adjusted with respect to brightness and 
contrast to bring forth the individual bands (Photoshop [Adobe] at 8-bit gray level resolution). Therefore, visual perception of the band intensity in the im-
ages is skewed and does not necessarily match the analytical bar graph. (B) Chemiluminescent image of a Western blot of wild-type and mutant cells as-
sayed for the protein level of STIM1 and tubulin. SDS-PAGE–separated total protein samples were blotted and subsequently identiﬁ  ed with speciﬁ  c primary 
antibodies. The level of expression was determined by the gray level of chemiluminescent images of the identiﬁ  ed protein bands. Within the resolution of 
the technique, STIM1 protein levels are not different in wild-type and mutant cells. (C) Images of ethidium bromide–stained DNA bands in an agarose gel. 
DNA was obtained by PCR ampliﬁ  cation of cDNA using primers speciﬁ  c for STIM1, Orai11, and β-actin. PCR reactions were performed in serially diluted 
(1:5) samples of the same starting cDNA. After identical PCR reactions, DNA products were size separated by gel electrophoresis, and the gel was stained 
with ethidium bromide. DNA levels were assessed by the gray level in the images. Within the resolution of the technique, STIM1 and Orai11 mRNA levels 
are not different in wild-type and mutant cells.JCB • VOLUME 177 • NUMBER 2 • 2007  326
release and Icrac activation (Zhang et al., 2005; Feske et al., 
2006; Peinelt et al., 2006). They are both integral membrane 
proteins located either in the ER membrane (STIM1) or in the 
plasma membrane (Orai1). Their simultaneous coexpression 
enhances Ca
2+-dependent Icrac gating. These may be the fi  rst 
identifi  ed constituents of a larger family of proteins involved in 
the linkage between Ca
2+ store release and channel gating. The 
results we present here fi  rmly indicate that the link between 
the release of Ca
2+ stores and Icrac activation in B cells also 
involves protein phosphorylation catalyzed by cytoplasmic 
tyrosine kinases. The target of phosphorylation remains to be 
identifi  ed in future work; it could be STIM1, Orai1, or other 
proteins yet to be discovered. However, we have demonstrated 
that kinase activity does not affect the expression levels of 
STIM1 or Orai1.
We emphasize that our results suggest that the state of 
phosphorylation of a target protein is important, but we have no 
evidence, nor do we suggest that Ca
2+ sensing or channel gating 
is mediated by phosphorylation. We assayed kinase autophos-
phorylation as an index of enzymatic activity. Our biochemical 
results reveal that the activity of one of the critical kinases (Syk) 
does not change with Ca
2+ release, whereas the other (Lyn) 
changes only by a small extent and with a slow time course. We 
propose that phosphorylation is required as a tonic signal that 
sustains the normal function of its target protein rather than a 
phasic signal activated in the course of Ca
2+ release, Ca
2+ sensing, 
or channel gating.
Materials and methods
Materials
IP3, TG, ionomycin, ﬁ  bronectin, antiphosphotyrosine antibody 4G10, 
  LavendustinA, and PP2 (4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]
pyrimidine) were obtained from Calbiochem. The STIM1 antibody was 
purchased from BD Biosciences. M4, an anti-DT40 BCR chain mAb, was 
prepared as described previously (Zhao and Weiss, 1996). Indo1–acetoxy-
methyl and Fura2–acetoxy-methyl were obtained from Invitrogen. Phospho-
Src family (P-Y416) and phospho–Zap-70 (P-Y319)/Syk (P-Y352) anti bodies 
were purchased from Cell Signaling Technology. pLynGFP and pSykEGPF, 
which were gifts from A. Defranco (University of California, San Fransisco, 
San Fransisco, CA), are vectors that promote the expression of Lyn/GFP or 
Syk/EGFP proteins.
Cell lines and solutions
DT40 cells were cultured at 37°C in 5% CO2 in RPMI 1640 with 10% FCS, 
1% chicken serum, and 2 mM glutamine. Generation of every cell mutant 
DT40 cell line has been reported previously: lyn/syk
−/− and btk
−/− (Takata 
and Kurosaki, 1996), lyn
− and syk
− (Takata et al., 1994), and bln
− (Ishiai 
et al., 1999). Mutant cells were transfected with pLynGFP or pSykEGPF by 
electroporation and grown for 24 h after transformation before Ca
2+ imag-
ing experiments.
DT40 Ringer’s solution consisted of 145 mM NaCl, 2.8 mM KCl, 
10 mM CsCl, 10 mM CaCl2, 2 mM MgCl2, 10 mM glucose, and 10 mM 
Hepes-NaOH, pH 7.4. Tight-seal electrodes were ﬁ  lled with a quasi-
  intracellular solution of the composition 145 mM Cs glutamate, 8 mM 
NaCl, 1 mM MgCl2, 2 mM MgATP, 10 mM EGTA, and added Ca
2+ to 
yield 90 nM of free Ca
2+. Free Ca
2+ in the presence of the various Ca
2+-
binding molecules was calculated using WinMaxC.
In some experiments, we tested the ion selectivity of Icrac by measuring 
the current in an extracellular solution consisting of 150 mM Na methane-
sulfonate, 10 mM Hepes, pH 7.4, and 2 mM EGTA with varying amounts 
of Ca
2+, Ba
2+, and Cd
2+. Osmotic pressure was 300 mosM (adjusted with 
glucose). In only these experiments, we ﬁ  lled the tight-seal electrode with 
128 mM Cs glutamate, 3.16 mM MgCl2, and 10 mM EGTA and added 
Ca
2+ to yield 90 nM of free ion.
Electrophysiological studies in single cells
Cells were washed free of incubation medium and resuspended at  10
5/ml 
in Ringer’s solution. 200 μl of the cell suspension was applied onto a 
  ﬁ  bronectin-coated glass coverslip that formed the bottom of a recording 
chamber held on an upright microscope (Diaphot; Nikon) equipped 
with differential interference contrast optics. The cells were maintained at 
room temperature and continuously superfused with oxygenated record-
ing solution. Drugs of interest were tested by adding them to the super-
fusing solution.
We measured membrane currents under voltage clamp at room tem-
perature in the whole cell mode conﬁ  guration using tight-seal electrodes 
produced from aluminosilicate glass (1.5 × 1.0 mm [outer diameter × inner 
diameter]; 1724; Corning). We used a patch-clamp ampliﬁ  er (Axopatch 
1B; Axon Instruments, Inc.), with which we compensated (and measured) 
membrane capacitance but not series resistance. Analogue signals were 
low-pass ﬁ  ltered below 1 KHz with an 8-pole Bessel ﬁ  lter (Frequency 
  Devices) and digitized online at 3 KHz with FastLab (Indec Systems) or 
pClamp (Axon Instruments, Inc.). Bath was grounded through an Ag/AgCl 
electrode connected to the solution via a 1-M KCl agar bridge to avoid 
shifts in electrode potential as solutions changed.
Two voltage command protocols were used, steps or ramp, depend-
ing on the purpose of the experiment. In the voltage step protocol, voltage 
was held at 0 mV and was stepped for 160 ms to values between −100 
and 90 mV in 10-mV increments. This protocol was applied immediately 
after attaining whole cell mode and before adding any stimulant. The I-V 
curve thus generated was deﬁ  ned as the cells leak. Cells were chemically 
stimulated, and the voltage step protocol was executed again 2 min there-
after. The I-V curves are corrected for nonspeciﬁ  c electrical leakage. This 
correction was carried out by measuring the I-V curve before chemical 
subtraction and subtracting these data from the I-V curve measured after 
stimulation. Continuous I-V functions were ﬁ  t to discrete data points with a 
second degree polynomial using nonlinear least-square minimization algo-
rithms (Origin; Microcal).
To investigate the time course of Icrac development and the effects of 
LavendustinA, we used a voltage ramp protocol. Voltage was held at 0 mV, 
and acquisition epochs were repeated continuously at 3-s intervals starting 
immediately after attaining whole cell mode and for as long as 25 min. In 
each acquisition epoch, voltage was initially stepped to −100 mV for 100 ms, 
and then a linear voltage ramp was applied between −100 and 100 mV 
over 100 ms before returning to −100 mV for another 100 ms. To deter-
mine the time course of Icrac development, we measured in each of the 
successive epochs the difference between the mean current amplitude at 0 mV 
and the amplitude 90 ms after stepping to −90 mV. The cell’s I-V curve was 
measured directly from the ramp data.
Measurement of cytoplasmic free Ca
2+ in cell suspensions
To load, Indo1 was loaded into cells by incubating  3 × 10
6 cells/ml in 
RPMI 1640 with 10% FBS and 3 μM Indo1–acetoxy-methyl (Invitrogen) for 
1 h at 37°C. The cells were then washed three times at room temperature 
with a DT40 Ringer’s solution consisting of 125 mM NaCl, 5 mM KCl, 1 mM 
CaCl2, 0.5 mM MgCl2, 1 mM Na2HPO4, 11 mM glucose, and 25 mM 
Hepes, pH 7.4, with 0.1% wt/vol BSA added. The last cell pellet was 
maintained on ice until just before measurements. To measure Ca
2+,  2 × 
10
6 Indo-loaded cells/ml were suspended in DT40 Ringer’s solution with 
BSA and maintained at 37°C in a stirred cuvette in a ﬂ  uorimeter (F-4500; 
Hitachi). Fluorescence emission intensity ratio at 400 and 500 nm (F400/
F500) was measured continuously and assessed in response to stimulants 
injected into the stirred cuvette.
Single-cell Ca
2+ imaging
In single-cell studies, we used the ﬂ  uorescent dye Fura2 in a modiﬁ  ed 
  epiﬂ  uorescent microscope. Cells were loaded by incubation in Fura2–
  acetoxy-methyl (Invitrogen) as described above for Indo1–acetoxy-methyl. 
Immediately after the last wash, cells were suspended in DT40 Ringer’s so-
lution at  10
5 cells/ml, and 200 μl was deposited on an imaging chamber 
held on the stage of the inverted microscope. The bottom of this chamber 
was a glass coverslip coated with 0.1 mg/ml poly-L-lysine, to which cells 
adhered. Cell ﬂ  uorescence was excited at either 340 or 380 nm (narrow 
band interference ﬁ  lters selected with a rotating wheel; Sutter Instrument 
Co.). Cells were observed using a 20× 0.75 NA Fluor objective (Nikon), 
and images were captured through a 510 ± 40-nm bandpass optical win-
dow using a cooled high resolution CCD camera (MicroMAX 1300; Roper 
Scientiﬁ  c), an ST133 controller, and WinView32 software (Roper Scientiﬁ  c). 
Image pairs at 340 or 380 nm were acquired for 5 s each, separated by 
0.5 s from one another. Image pairs were repeated at 30-s intervals over TYROSINE KINASES AND ICRAC GATING • CHUNG ET AL. 327
20 min. To minimize ﬂ  uorophore bleaching, an electronic shutter (LPS25; 
Vincent Associates) was used to restrict cell illumination to the time of 
image acquisition.
In off-line analysis (Simple PCI software; Compix, Inc.), we selected 
images of individual cells that met three criteria: diameter within 10% of 
the population mean, low resting cytoplasmic Ca
2+, and no detectable 
movement or loss of focus over the time course of the measurements. The 
mean gray level (at 10 bit resolution) of the emission intensity at 340 and 
380 nm was measured for each selected cell at each time point and averaged 
over the cell population. Absolute cell emission intensity was calculated by 
subtracting the mean intensity of the background.
Single-cell superfusion
The cell-bathing Ringer’s solution in the microscope imaging chamber 
was exchanged throughout an experimental measurement at a rate of 
 0.5 ml/min. In addition, the medium speciﬁ  cally bathing cells in a selected 
ﬁ  eld of view was controlled by local superfusion with solutions ﬂ  owing 
from a 300-μm–inner diameter polyimide capillary tubing (PT Technologies) 
placed with its tip in the same plane as the cells and  300 μm away. This 
superfusing medium rapidly (≤200 ms) changed in the course of cyto-
plasmic Ca
2+ level measurements. The polyimide tubing was the exit port 
of micromanifold (MM-6; Warner Instruments) that allowed selection 
among six possible solutions. The identity and duration of ﬂ  ow of the 
superfusing solution were controlled with electronic switch valves (MPS-2; 
WPI Instruments).
Tyrosine phosphorylation assay
1.0 × 10
8 DT40 cells were suspended in RPMI, stimulated by the addi-
tion of TG or M4, and sampled at different time points after stimulation. 
Cells were spun, lysis buffer was added, cells were spun again, and the 
supernatant was collected. 4G10 antibody was added to the supernatant 
and incubated for 1 h at 4°C on a rocker. Protein G beads were then 
added, and the suspension was incubated for an additional 2 h at 4°C. 
The beads with bound tyrosine-phosphorylated proteins were washed 
four times with lysis buffer and dissolved in standard SDS sample buffer 
with DTT. Proteins were separated in gradient 5–15% SDS-PAGE, blotted 
onto nitrocellulose, and reacted with antibodies. The reaction product 
was located on the blot with secondary antibodies linked to HRP and re-
acted with the chemiluminescent substrate Luminol. Within 1 min, lumi-
nescent images were acquired with a cooled high resolution CCD camera 
(MicroMAX 1300; Roper Scientiﬁ  c). In off-line image analysis (Simple 
PCI software; Compix), we measured the absolute gray level of each 
  luminescent band.
Expression levels of STIM1 and Orai1
Expression levels of STIM1 protein were assessed in a Western blot 
  using anti-STIM1 primary antibody and a secondary antibody linked to 
HRP. SDS-PAGE lanes were loaded with 200 μg of protein and trans-
ferred onto a nitrocellulose membrane, which was then incubated for 
2 h at room temperature with the primary antibody dissolved in 3% 
(wt/vol) BSA in Tween-PBS. After exhaustive washing, the membrane 
was further incubated with the secondary antibody for 1 h at room tem-
perature. The extent of antibody binding was assessed using chemilumi-
nescence (PerkinElmer).
The expression levels of STIM1 and Orai1 mRNA were assessed with 
semiquantitative RT-PCR. Total RNA from wild-type and mutant DT40 cells 
was puriﬁ  ed using the RNeasy kit (QIAGEN). First-strand cDNA was pro-
duced using the Superscript III ﬁ  rst-strand synthesis system (Invitrogen). Serial 
1:5 dilutions of the cDNAs were then used in PCR reactions using the prim-
ers of the following sequences: STIM1, forward (G  G  G  A  C  T  G  T  G  C  T  G  A  A  G-
A  T  G  A  C  A  G  A  C  C  G  ) and reverse (T  C  C  T  T  G  G  C  C  A  C  C  A  G  G  A  G  C  T  G  C  T  T  C  T  C  ); 
Orai1, forward (G  G  C  T  T  C  G  C  C  A  T  G  G  T  G  G  C  C  A  T  G  G  T  A  G  A  ) and reverse 
(T  C  A  C  C  C  A  A  C  A  C  A  G  C  A  A  C  A  C  C  A  C  C  T  C  ); and β-actin, forward (C  C  C  T  C  C-
C  C  C  A  T  G  C  C  A  T  C  C  T  C  ) and reverse (C  C  G  G  T  T  T  A  G  A  A  G  C  A  T  T  T  G  C  G  G  ).
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